Bio & Pharma
Bio & Pharma
Samsung Biologics reaches record-breaking annual orders
Nov 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector i...
Nov 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for C...
Nov 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
GC Biopharma wins $10 mn order for flu vaccine in Thailand
South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gove...
Nov 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK C&C to promote AI healthcare for brain diseases
South Korea's SK C&C announced on Thursday that it signed a strategic business agreement with Neurophet, a cloud-based AI platform for brain imag...
Nov 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
KAIST, IVI to collaborate on global vaccine research
The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the In...
Nov 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Pharmteco launches new viral vector platforms, key for CGT
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has recently introduced two ...
Nov 22, 2023 (Gmt+09:00)
4 Min read -
Bio & Pharma
SK Bioscience to develop 2nd-generation Ebola vaccine
South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization Hi...
Nov 22, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Cytogen, Japan NCCH collaborate on cancer research
South Korea's Cytogen, Inc. announced on Monday it will start cancer research using circulating tumor cells (CTC) with the National Cancer Center Hos...
Nov 20, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Med. Center achieves Korea's first uterine transplantation
The first successful case of uterine transplantation surgery in Korea has been reported, with the patient currently preparing for pregnancy. Samsung ...
Nov 17, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Biopharm gears up to boost epilepsy drug sales in Europe
SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and a...
Nov 16, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth ...
Nov 15, 2023 (Gmt+09:00)
3 Min read -
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the be...
Nov 13, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Celltrion to supply Remsima to Brazil gov’t in three-year row
South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the Br...
Nov 10, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Lunit participates in US gov't Cancer Moonshot
South Korea's medical AI company Lunit announced on Friday it will participate in the US President Joe Biden's cancer-conquering project Cancer Moons...
Nov 10, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Biopharma’s Cenobamate US patent extended by 2032
South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oct...
Nov 10, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
JLK supplies AI stroke solutions to Philippines
JLK Inc., South Korea's stroke diagnosis specialist company, announced on Thursday it implemented two artificial intelligence (AI) stroke diagnostic ...
Nov 09, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Doctornow signs business agreement with Spain’s Mediktor
South Korea's medical care startup Doctornow Inc. announced on Wednesday it signed a strategic business agreement with global artificial intelligence...
Nov 08, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Gencurix gets FDA OK for breast cancer prognosis analysis device
South Korean biotech company Gencurix Inc. announced on Wednesday its subsidiary GenoBio has received approval from the US Food and Drug Administrati...
Nov 08, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Chong Kun Dang rallies on $1.3 bn deal with Novartis
Chong Kun Dang Pharmaceutical Corp.'s shares zoomed more than 25% on Monday on news that the South Korean medicine developer has signed its biggest-e...
Nov 06, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Dong-A ST, UMass to jointly research for gene therapy
South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical School...
Nov 03, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Naver-invested ichrogene enters Thai market
South Korea's digital healthcare startup ichrogene, with investment from Naver D2 Startup Factory (D2SF), entered into Thai market. Naver Corp. on We...
Nov 01, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Engineering secures $349 mn bio plant deal
South Korea's Samsung Engineering secured a deal for the Songdo Bio Raw Material Plant construction project from the global life sciences and laborat...
Nov 01, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Daewoong Pharma, Merck team up for AI tech for new drug
South Korea's Daewoong Pharmaceutical announced on Tuesday it signed with memorandum of understanding (MOU) with Merck Life Science to build an artif...
Oct 31, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bil...
Oct 31, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Samsung Biologics eyes new drugmaker acquisitions
BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugmak...
Oct 27, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Theraject Asia applies for microneedle patent in US
South Korean microneedle company Theraject Asia on Thursday said it recently applied for a US patent for a medical microneedle, specifically a consta...
Oct 27, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate ...
Oct 26, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Bioepis gets FDA OK for its interchangeable biosimilar
Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official designat...
Oct 25, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Medytox to enter China’s botulinum toxin market with Newlux
South Korean pharmaceutical company Medytox Inc. on Tuesday announced its plan to enter the Chinese market for botulinum toxins (BTX) with its cutti...
Oct 25, 2023 (Gmt+09:00)
1 Min read
Hidden Champions
-
DCM
Published: Dec 09, 2022
Last updated: Jan 30, 2023
-
Koh Young Technology Inc
Published: Sep 21, 2020
Last updated: Jan 20, 2023
-
Jong Ie Nara
Published: May 26, 2021
Last updated: Apr 15, 2022
-
Buhmwoo Group
Published: Apr 21, 2021
Last updated: Jan 30, 2023
-
Point Mobile
Published: Sep 14, 2021
Last updated: May 10, 2022
Future Unicorns
Latest News